{"transactions":[{"id":1176742,"issuer":{"id":9617,"kind":"organization","name":"Anebulo Pharmaceuticals, Inc."},"owners":[{"id":81019,"kind":"person","name":"Calloway Nathaniel","position":1,"cik":"0001952771","reported_name":"Calloway Nathaniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-04-08T01:41:31.000Z","date":"2025-04-04","kind":"grant","planned":false,"acquired":true,"shares":3309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of April 4, 2026 or the date of the 2026 annual meeting of shareholders."}],"balance_after":3309,"derivative":{"exercise_price":1.02,"expiration_date":"2035-04-03","underlying":"Common Stock","underlying_shares":3309},"source":{"system":"sec-edgar","filing":"0001641172-25-003094","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815974/000164117225003094/ownership.xml","form_type":"4"}},{"id":1176741,"issuer":{"id":9617,"kind":"organization","name":"Anebulo Pharmaceuticals, Inc."},"owners":[{"id":81019,"kind":"person","name":"Calloway Nathaniel","position":1,"cik":"0001952771","reported_name":"Calloway Nathaniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-04-08T01:41:31.000Z","date":"2025-04-04","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of April 4, 2026 or the date of the 2026 annual meeting of shareholders."}],"balance_after":25000,"derivative":{"exercise_price":1.02,"expiration_date":"2035-04-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001641172-25-003094","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815974/000164117225003094/ownership.xml","form_type":"4"}},{"id":1457096,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":81019,"kind":"person","name":"Calloway Nathaniel","position":1,"cik":"0001952771","reported_name":"Calloway Nathaniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-10T23:52:03.000Z","date":"2024-07-08","kind":"grant","planned":false,"acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Vests on earlier of the first anniversary of the grant date or the date of the annual meeting of stockholders first held in calendar year 2025, subject to potential acceleration."}],"balance_after":58069,"source":{"system":"sec-edgar","filing":"0001628280-24-031634","document":"wk-form4_1720655516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828024031634/wk-form4_1720655516.xml","form_type":"4"}},{"id":1477429,"issuer":{"id":9617,"kind":"organization","name":"Anebulo Pharmaceuticals, Inc."},"owners":[{"id":81019,"kind":"person","name":"Calloway Nathaniel","position":1,"cik":"0001952771","reported_name":"Calloway Nathaniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-17T20:23:52.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":1655,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options vest on the earlier of November 30,2024 or the date of the 2024 annual meeting of shareholders"}],"balance_after":1655,"derivative":{"exercise_price":2.1,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":1655},"source":{"system":"sec-edgar","filing":"0001493152-24-024126","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815974/000149315224024126/ownership.xml","form_type":"4"}},{"id":1477428,"issuer":{"id":9617,"kind":"organization","name":"Anebulo Pharmaceuticals, Inc."},"owners":[{"id":81019,"kind":"person","name":"Calloway Nathaniel","position":1,"cik":"0001952771","reported_name":"Calloway Nathaniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-17T20:23:52.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":41667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options vest 50% on the date of the 2024 annual meeting of shareholders and 50% on the one year anniversary of the date of grant"}],"balance_after":41667,"derivative":{"exercise_price":2.1,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":41667},"source":{"system":"sec-edgar","filing":"0001493152-24-024126","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815974/000149315224024126/ownership.xml","form_type":"4"}},{"id":1662578,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":81019,"kind":"person","name":"Calloway Nathaniel","position":1,"cik":"0001952771","reported_name":"Calloway Nathaniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-02-02T23:41:59.000Z","date":"2024-02-01","kind":"exercise","planned":false,"acquired":false,"shares":3981,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vested on February 1, 2024."}],"balance_after":0,"derivative":{"exercise_date":"2024-02-01","underlying":"Common Stock","underlying_shares":3981},"source":{"system":"sec-edgar","filing":"0001628280-24-003139","document":"wk-form4_1706917311.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828024003139/wk-form4_1706917311.xml","form_type":"4"}},{"id":1662577,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":81019,"kind":"person","name":"Calloway Nathaniel","position":1,"cik":"0001952771","reported_name":"Calloway Nathaniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-02T23:41:59.000Z","date":"2024-02-01","kind":"exercise","planned":false,"acquired":true,"shares":3981,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis."}],"balance_after":28069,"source":{"system":"sec-edgar","filing":"0001628280-24-003139","document":"wk-form4_1706917311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828024003139/wk-form4_1706917311.xml","form_type":"4"}},{"id":1681917,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":81019,"kind":"person","name":"Calloway Nathaniel","position":1,"cik":"0001952771","reported_name":"Calloway Nathaniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-01-11T00:14:35.000Z","date":"2024-01-09","kind":"exercise","planned":false,"acquired":false,"shares":5906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vested on January 9, 2024."}],"balance_after":0,"derivative":{"exercise_date":"2024-01-09","underlying":"Common Stock","underlying_shares":5906},"source":{"system":"sec-edgar","filing":"0001628280-24-001074","document":"wk-form4_1704932063.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828024001074/wk-form4_1704932063.xml","form_type":"4"}},{"id":1681916,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":81019,"kind":"person","name":"Calloway Nathaniel","position":1,"cik":"0001952771","reported_name":"Calloway Nathaniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-11T00:14:35.000Z","date":"2024-01-09","kind":"exercise","planned":false,"acquired":true,"shares":5906,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis."}],"balance_after":24088,"source":{"system":"sec-edgar","filing":"0001628280-24-001074","document":"wk-form4_1704932063.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828024001074/wk-form4_1704932063.xml","form_type":"4"}},{"id":1868039,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":81019,"kind":"person","name":"Calloway Nathaniel","position":1,"cik":"0001952771","reported_name":"Calloway Nathaniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-05T19:19:44.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":18182,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted Stock Units will vest and be settled on the earlier of the 1st anniversary of the grant date or the date of the 2024 Annual Meeting of Stockholders (provided such date is no less than 50 weeks from Grant Date)."}],"balance_after":18182,"source":{"system":"sec-edgar","filing":"0001628280-23-020835","document":"wk-form4_1685992772.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828023020835/wk-form4_1685992772.xml","form_type":"4"}},{"id":2037087,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":81019,"kind":"person","name":"Calloway Nathaniel","position":1,"cik":"0001952771","reported_name":"Calloway Nathaniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-02-02T22:30:26.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":3981,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Stock Units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Restricted Stock Units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock."}],"balance_after":3981,"derivative":{"exercise_date":"2024-02-01","underlying":"Common Stock","underlying_shares":3981},"source":{"system":"sec-edgar","filing":"0001628280-23-002097","document":"wf-form4_167537701261314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828023002097/wf-form4_167537701261314.xml","form_type":"4"}},{"id":2056834,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":81019,"kind":"person","name":"Calloway Nathaniel","position":1,"cik":"0001952771","reported_name":"Calloway Nathaniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-01-11T21:21:39.000Z","date":"2023-01-09","kind":"grant","acquired":true,"shares":5906,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock."}],"balance_after":5906,"derivative":{"exercise_date":"2024-01-09","underlying":"Common Stock","underlying_shares":5906},"source":{"system":"sec-edgar","filing":"0001628280-23-000899","document":"wf-form4_167347208527160.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828023000899/wf-form4_167347208527160.xml","form_type":"4"}},{"id":2127249,"issuer":{"id":9617,"kind":"organization","name":"Anebulo Pharmaceuticals, Inc."},"owners":[{"id":81019,"kind":"person","name":"Calloway Nathaniel","position":1,"cik":"0001952771","reported_name":"Calloway Nathaniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-11-02T20:31:58.000Z","date":"2022-11-01","kind":"grant","acquired":true,"shares":59149,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the original number of shares vest on the first anniversary of November 1, 2022 (the \"Vesting Commencement Date\") and 2.0833% of the original number of shares vest at the end of each successive month following the first anniversary of the Vesting Commencement Date until the fourth anniversary of the Vesting Commencement Date."}],"balance_after":59149,"derivative":{"exercise_price":2.9,"expiration_date":"2027-10-31","underlying":"Common Stock","underlying_shares":59149},"source":{"system":"sec-edgar","filing":"0001209191-22-055300","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815974/000120919122055300/doc4.xml","form_type":"4"}}]}